Oxidative stress in human hypertension: Association with antihypertensive treatment, gender, nutrition, and lifestyle

Free Radical Biology and Medicine

Volumn 36, Issue 2, 2004, Pages 226-232

  Ward, Natalie C ^a,b   Hodgson, Jonathan M ^a   Puddey, Ian B ^a   Mori, Trevor A ^a   Beilin, Lawrence J ^a   Croft, Kevin D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b School of Medicine and Pharmacology ^*  (Australia)

Author keywords

F2 isoprostanes; Free radicals; Gender; Hypertension; Lifestyle; Nutrition; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROSTANE DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NUTRIENT; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; URINALYSIS;

EID: 1642546344     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.10.021     Document Type: Article

References (38)

1. Kumar K.V., Das U.N. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic. Res. Commun. 19:1993;59-66.
2. Lacy F., Kailasam M.T., O'Connor D.T., Schmid-Schonbein G.W., Parmer R.J. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender and ethnicity. Hypertension. 36:2000;878-884.
3. Zalba G., San Jose G., Moreno M.U., Fortuno M.A., Fortuno A., Beaumont F.J., Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension. 38:2001;1395-1399.
4. Makino A., Skelton M.M., Zou A.P., Roman R.J., Cowley A.W. Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension. 39:2002;667-672.
5. McCord J.M. The evolution of free radicals and oxidative stress. Am. J. Med. 108:2000;652-659.
6. Pedro-Botet J., Covas M.I., Martin S., Rubies-Prat J. Decreased endogenous antioxidant enzymatic status in essential hypertension. J. Hum. Hypertens. 14:2000;343-345.
7. Ide T., Tsutsui H., Ohashi N., Hayashidani S., Suematsu N., Tsuchihashi M., Tamai H., Takeshita A. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler. Thromb. Vasc. Biol. 22:2002;438-442.
8. Block G., Dietrich M., Norkus E.P., Morrow J.D., Hudes M., Caan B., Packer L. Factors associated with oxidative stress in human populations. Am. J. Epidemiol. 156:2002;274-285.
9. Ghiadoni L., Magagna A., Versari D., Kardasz I., Huang Y., Taddei S., Salvetti A. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 41:2003;1281-1286.
10. Minuz P., Patrignani P., Gaino S., Degan M., Menapace L., Tommasoli R., Seta F., Capone M.L., Tacconelli S., Palatresi S., Bencini C., Del Vecchio C., Mansueto G., Arosio E., Santonastaso C.L., Lechi A., Morganti A., Patrono C. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation. 106:2002;2800-2805.
11. Cracowski J.L., Baguet J.P., Ormezzano O., Bessard J., Stanke-Labesque F., Bessard G., Mallion J.M. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension. 41:2003;286-288.
12. Morrow J.D., Roberts L.J. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36:1997;1-21.
13. Booth M.L., Owen N., Bauman A.E., Gore C.J. Retest reliability of recall measures of leisure-time physical activity in Australian adults. Int. J. Epidemiol. 25:1996;153-159.
14. Hodge A., Patterson A.J., Brown W.J., Ireland P., Giles G. The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust. N.Z. J. Public Health. 24:2000;576-583.
15. Lewis J., Holt R. Nutrient Tables for Use in Australia. 1991;National Food Authority, Canberra.
16. Beilin L.J. Role of automated measurements in understanding lifestyle effects on blood pressure. Blood Press Monit. 7:2002;45-50.
17. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 21:2003;1011-1053.
18. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. 17:1999;151-183.
19. Mori T.A., Croft K.D., Puddey I.B., Beilin L.J. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal. Biochem. 268:1999;117-125.
20. Cao G., Verdon C.P., Wu A.H., Wang H., Prior R.L. Automated assay of oxygen radical absorbance capacity with the COBAS FARA II. Clin. Chem. 41:1995;1738-1744.
21. Cao G., Prior R.L. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol. 299:1999;50-62.
22. McCulloch R.K., Vandongen R. Measurement of ascorbic acid in platelets and its relationship to polymorphonuclear leukocyte levels. Clin. Chim. Acta. 213:1992;15-22.
23. Su Q., Rowley K.G., O'Dea K. Stability, of individual carotenoids, retinol and tocopherols in human plasma during exposure to light and after extraction. J. Chromatogr. B Biomed. Sci. Appl. 729:1999;191-198.
24. Trevisan M., Browne R., Ram M., Muti P., Freudenheim J., Carosella A.M., Armstrong D. Correlates of markers of oxidative status in the general population. Am. J. Epidemiol. 154:2001;348-356.
25. Enseleit F., Hurlimann D., Luscher T.F. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. J. Cardiovasc. Pharmacol. 37(Suppl 1):2001;S21-S30.
26. 2 production and S-thiolation. Free Radic. Biol. Med. 27:1999;623-635.
27. Meagher E.A., Barry O.P., Burke A., Lucey M.R., Lawson J.A., Rokach J., FitzGerald G.A. Alcohol-induced generation of lipid peroxidation products in humans. J. Clin. Invest. 104:1999;805-813.
28. Hashimoto Y., Futamura A., Nakarai H., Nakahara K. Relationship between response of gamma-glutamyl transpeptidase to alcohol drinking and risk factors for coronary heart disease. Atherosclerosis. 158:2001;465-470.
29. Duffy S.J., Gokce N., Holbrook M., Huang A., Frei B., Keaney J.F. Jr., Vita J.A. Treatment of hypertension with ascorbic acid. Lancet. 354:1999;2048-2049.
30. Hajjar I.M., George V., Sasse E.A., Kochar M.S. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am. J. Ther. 9:2002;289-293.
31. Block G., Mangels A.R., Norkus E.P., Patterson B.H., Levander O.A., Taylor P.R. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension. 37:2001;261-267.
32. Jacques P.F. A cross-sectional study of vitamin C intake and blood pressure in the elderly. Int. J. Vitam. Nutr. Res. 62:1992;252-255.
33. Salonen J.T. Clinical trials testing cardiovascular benefits of antioxidant supplementation. Free Radic. Res. 36:2003;1299-1306.
34. Jialal I., Devaraj S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation. 107:2003;926-928.
35. Thomas S.R., Stocker R. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis. Free Radic. Biol. Med. 28:2000;1795-1805.
36. Chen J., He J., Hamm L., Batuman V., Whelton P.K. Serum antioxidant vitamins and blood pressure in the United States population. Hypertension. 40:2002;810-816.
37. 2-isoprostanes and plasma antioxidant potential. Nephrol. Dial. Transplant. 16:2001;1626-1630.
38. Nieto F.J., Iribarren C., Gross M.D., Comstock G.W., Cutler R.G. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 148:2000;131-139.